Overview
This page covers kambo, the skin secretion of Phyllomedusa bicolor, as used by several Amazonian peoples in hunting and purification contexts and as offered in Western ceremonies. It outlines the peptide pharmacology, the lack of controlled human studies, published case reports of serious harm, and debates over appropriation and harvest.
Where does Kambo come from?
Use among Pano-speaking and neighboring peoples
Kambô is the skin secretion of the Amazonian frog Phyllomedusa bicolor. A transdisciplinary review reports that it is used by hunters in the southwest Amazon, among them the Yawanawá, Kaxinawá, Matsés and Mayoruna, and especially the Katukina, and that the ethnological literature records use in more than 15 Indigenous groups from five linguistic families across Bolivia, Brazil, Colombia, Peru, French Guiana, Suriname and Venezuela. The same review notes that speakers of Pano languages also apply it to their hunting dogs.
An ethnographic article on its use in Brazil describes the Katukina, Yawanawá and Kaxinawá as using it as a stimulant and invigorating agent for hunting. A conservation commentary adds the Noke Koĩ, Huni Kuĩ, Tikuna and Waiãpi to the peoples named. Uses and meanings differ between these groups, and the sources reviewed here do not describe them in equal detail.
Early documentation and spread beyond Indigenous communities
According to the review, the first ethnographic observations in the upper and middle Juruá region were made by the French missionary Constantin Tastevin in 1925. It also relays an origin account from the Kaxinawá in which a shaman, after ayahuasca rituals did not relieve many seriously ill people, received a message in the forest from a deity holding a green frog. This is a narrative held within that tradition and not a dated historical record.
The review states that from the 19th century, contact between Indigenous people and rubber tappers in the Juruá valley led to riverine and rubber-tapper adoption, and credits Francisco Gomes Muniz with expanding the practice in Acre and with the first applications in urban centers. Labate and Lima date diffusion to Brazilian cities to the mid-1990s and to Europe and North America to the late 2000s, through alternative therapy clinics, Brazilian ayahuasca religions and travel by rubber tappers, Katukina and Kaxinawá people.
A conservation commentary names Muniz, known as Shimbam, as the person who introduced kambô to urban Brazilian ayahuasca communities in the 1990s, and says that after his death it spread through neoshamanic and New Age networks, sometimes described as a panacea.
What do the names and terms mean?
Names for the frog and the secretion
Scientific papers use Kambo or Kambô both for the frog and for its dried secretion, which is sold on small wooden sticks. The frog is also called the giant monkey frog, giant leaf frog, giant maki frog, waxy monkey tree frog or two-colored leaf frog. In Portuguese the practice is called the toad vaccine, vacina do sapo, and some case reports use the term sapo.
Concepts attached to the practice
Panema is described in the literature as bad luck and a type of weakness that the secretion is traditionally said to ward off. In Western settings the practice is often described as cleansing or detoxification, and detoxification appears among the motivations users report in surveys. The systematic review notes that it has been marketed as a detox treatment.
Labate and Lima describe two competing ways urban users talk about it: as a remedy of science, stressing the biochemistry of the peptides, and as a remedy of spirit, stressing Indigenous origins and shamanic associations. The term neoshamanic is used in the review for Western ceremonies, and the process of reworking the practice for urban therapeutic settings has been labeled the shamanization of kambô.
What does Kambo involve?
Collection of the secretion in traditional settings
The review describes traditional collection as taking place at dawn, guided by the frog's call, after which the animal is released. Native collectors are reported to avoid harming the animal or taking excessive amounts, and to hold that injuring it can offend animal spirits. This is an overview drawn from published ethnography and is not a guide to collection or preparation.
What a session involves
In reported descriptions, an applicator makes small superficial burns on the skin and applies the secretion to the open wounds, so that its peptides are absorbed through damaged skin. Reviews describe fasting beforehand and drinking fluids, followed within minutes by flushing, a racing heart, sweating and vomiting that generally subsides in about an hour and then gives way to drowsiness. Participants afterward often report a feeling of clarity and strength.
Placement of the application sites varies by people and by gender in the ethnographic reports. Among Western participants the ritual is often held in a ceremonial setting with singing, instruments, incense and prayers, and other traditional preparations such as tobacco snuff or sananga eye drops are sometimes given nearby. The sources do not describe a standard format, and no uniform training or qualification for applicators is documented in them.
What is Kambo used for?
Traditional purposes
In traditional hunting contexts the secretion is described as a means of purifying the body, bringing luck to hunters and increasing stamina and physical and sexual strength. It is also reported to ward off panema. These are purposes held within the traditions that use it and are not outcomes that have been tested in the research literature reviewed here.
Reasons given by people outside Amazonian communities
An online survey of 386 mostly English- and German-speaking users found motivations that included general healing, detoxification and spiritual growth. A study of non-Indigenous users in Rondônia, Brazil, summarized in the review, reports curiosity and health problems such as rheumatism and diabetes as common reasons.
The review also lists conditions for which proponents have suggested benefit, including addiction, depression, chronic pain, autoimmune disorders, infections and cancer. A systematic review of death and survival reports observes that it has attracted people with cancer who report finding no benefit from conventional care. Those claims are quoted here as claims and are not supported by controlled evidence.
What does the research show?
Controlled studies of benefit
No randomized or other controlled human trial of kambô for any condition was found. A PubMed search for the term kambo restricted to randomized controlled trial, clinical trial, systematic review and meta-analysis publication types returned no records, and a search combining Phyllomedusa with randomized controlled trial also returned none. The transdisciplinary review states that beneficial effects have not been tested in randomized controlled trials and that any effect may be placebo. The one systematic review identified synthesized harm reports only.
Peptide pharmacology
The secretion contains many bioactive peptides. Deltorphins and dermorphins are opioid peptides, with deltorphins binding delta opioid receptors and dermorphins mu receptors, and a 1989 paper reported deltorphins from P. bicolor skin as having very high affinity for delta binding sites in laboratory preparations. Other constituents named in the review include phyllokinin, which lowers blood pressure in dogs, sauvagine, which has hypotensive and antidiuretic actions in rats, and phyllocaerulein, considered the most abundant and linked to nausea and vomiting.
These findings come from isolated peptides in cells, tissue and animals. The review notes that studies of the whole secretion are few and give uncertain results, and the mechanisms of its effects in people are not fully understood. Laboratory activity of a peptide should not be read as evidence that applying the crude secretion to skin helps any condition.
Surveys of users
In a retrospective study of 22 anonymous users, acute psychological effects were rated mild to moderate with no psychedelic-type distortions of perception or thinking, and persisting effects were mostly described as positive with high personal and spiritual significance. In the larger survey of 386 users, 87.31 percent reported increased well-being or life satisfaction, and 2.85 percent reported long-lasting physical and 1.81 percent mental health problems they attributed to it.
Both studies rely on self-selected volunteers looking back on past experiences, with no comparison group or objective measures. The survey authors state that more research is needed to separate the contributions of setting and expectation, so the results describe how users view their experience and do not show an effect of the secretion.
Cultural Context and Debates
Appropriation and benefit-sharing
As urban use grew in Brazil, Indigenous people, academics and commentators have criticized cultural appropriation of Indigenous knowledge, the way the secretion is extracted, how knowledge is transmitted, the price charged and the mystification of the frog's origin, according to a systematic review of harm reports. Labate and Lima's ethnography presents the practice as contested between medical and shamanic framings, with applicators ranging from Indigenous healers to former rubber tappers, holistic therapists and doctors.
The transdisciplinary review reports that in 2003 the Katukina denounced misuse and accused the pharmaceutical industry of patenting peptides and claiming the medicinal knowledge. A 2004 project joining the Katukina, researchers and the Brazilian government to regulate non-Indigenous use and recognize traditional knowledge did not get off the ground because of unresolved questions of ownership and benefit-sharing.
Frog populations and commercial harvest
The review states that Indigenous use appears to have remained sustainable but that expanding demand, including dried secretion sold online, could affect the species. The conservation commentary cites a researcher's concern about ecological impacts and notes that small farmers near Cruzeiro do Sul now harvest secretion for profit, unlike traditional practice, while saying further studies are needed to measure actual impacts. It also reports the belief among Indigenous peoples that harming the frog brings consequences from venomous snakes.
What are the safety considerations?
Common acute effects
Reviews describe intense short-term effects within minutes of application: vomiting, diarrhea, sweating, a fast heart rate, low blood pressure, facial swelling and fainting. One review cautions that the reactions can be mistaken for a massive allergic reaction, and the systematic review adds that hyperthermia and low blood sodium may be misread by participants as spiritual experiences.
Low blood sodium and brain swelling
Several case reports describe severe hyponatremia after rituals in which large volumes of water were also drunk. A 44-year-old woman in Slovenia who drank about six liters had plasma sodium of 116 mmol/L with findings of inappropriate antidiuretic hormone secretion, had a seizure and improved on saline and fluid restriction. A 41-year-old woman in Chile, who had also taken ayahuasca the previous night, had seizures, sodium of 120 mEq/L and rhabdomyolysis.
A 2025 case report describes a 35-year-old woman who developed headache, vomiting and a fixed dilated pupil within hours of a ritual, with diffuse cerebral edema and severe hyponatremia, and who progressed to brain death. The authors attribute this to excess water intake, sodium loss from vomiting and suspected inappropriate antidiuretic hormone secretion, and suggest clinicians consider kambô exposure when dot-like burns accompany acute neurologic decline.
Liver, esophagus, nerves and sudden death
A case report from Europe describes toxic liver damage probably associated with the ritual in a 34-year-old man, with raised enzymes and jaundice that resolved in about ten days after other causes were excluded. Esophageal rupture after severe vomiting has been reported, including a Boerhaave syndrome case in Australia. A 2026 case report describes a 40-year-old man with acute demyelinating polyneuropathy four days after self-application who needed intensive care and still had residual weakness at three months.
A forensic report describes a 42-year-old long-term user found dead with deltorphin A in his blood and left ventricular hypertrophy at autopsy, and its authors only suggest a possible link. The systematic review found only a few reported deaths, and notes that peptide detection is difficult, so cause is hard to establish. Case reports also describe psychosis after frequent use, dermatomyositis and an inflammatory response in a person with cholangiocarcinoma.
Suitability and limits of the evidence
The systematic review advises screening for pre-existing conditions, notes that the secretion has traditionally been used to induce abortion so that pregnant women should avoid it, and says children with low body mass may face higher exposure. It also warns that other amphibian secretions may be used by mistake. A literature review of poisoning reports found no shared treatment protocols. The number of users is unknown, so these reports cannot provide rates of harm. Anyone with severe vomiting, confusion, seizures, weakness, chest symptoms or collapse after a session needs emergency medical care, and such practices should not delay or replace necessary treatment.
Connected Entries
Showing 8 of 14 related records.
Classification and context
- Entry type
- Modality
- Practice type
- Amazonian skin-secretion ritual and its Western adaptations
- Traditions
- Katukina, Yawanawá, Kaxinawá (Huni Kuĩ), Matsés, Mayoruna, Rubber-tapper and Brazilian ayahuasca-religion settings, Western neoshamanic ceremonies
- Concepts
- Phyllomedusa bicolor, Panema, Cleansing and purification, Phyllokinin, Dermorphin, Deltorphin, Phyllocaerulein, Sauvagine, Hyponatremia, Cultural appropriation and benefit-sharing
- Categories
- Metaphysical, Alternative
Sources and discovery context
Research and public-health sources support evidence and safety context. Directory and discovery sources describe navigation, relationships, practitioners, and access—not clinical efficacy.
A narrative review combining frog biology, ethnological accounts, peptide pharmacology and clinical reports on the secretion.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports peoples named, ritual overview, peptide families, the no-RCT statement and adverse effects; must not be read as evidence of benefit or as a complete ethnography of any one people.
- Supports sections
- History and Origins, Terminology, Practice Description, Claimed Uses, Research and Evidence, Safety and Suitability
An anthropological article tracing kambô from Katukina, Yawanawá and Kaxinawá hunting use to urban Brazilian therapeutic and ayahuasca-religion settings.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports peoples named, diffusion dates, applicator types and the science-versus-spirit framings; does not support any health claim.
- Supports sections
- History and Origins, Terminology, Practice Description, Claimed Uses, Safety and Suitability
A commentary on frog conservation, commercial harvest and Indigenous perspectives on kambô.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports peoples named, the Muniz introduction, harvest and conservation concerns and Indigenous beliefs about the frog; ecological impact is stated as unmeasured and must not be inferred.
- Supports sections
- History and Origins, Safety and Suitability
A PRISMA-guided review of nine published fatal and non-fatal case reports and the forensic issues in identifying kambô peptides.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the harm patterns, forensic difficulty, suitability statements and criticism summary; case reports give no rates and must not be used to estimate frequency.
- Supports sections
- Terminology, Claimed Uses, Research and Evidence, Safety and Suitability
A review of acute intoxication cases published over ten years, with a proposed diagnostic and treatment algorithm.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the statements that acute intoxication occurs with serious effects and that no shared treatment protocol exists; the proposed algorithm is not endorsed here.
- Supports sections
- Safety and Suitability
A questionnaire study of 22 users using standardized altered-state and persisting-effects scales.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports 22-user self-reports of mild to moderate effects; cannot show any effect of the secretion or generalize beyond self-selected users.
- Supports sections
- Research and Evidence
An English and German online survey of 386 Western users covering motivations, settings and subjective effects.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports user-reported motivations and self-reported outcomes; self-selected and retrospective, with no comparator, so it cannot show benefit or rates of harm.
- Supports sections
- Terminology, Claimed Uses, Research and Evidence
A toxinology article describing the ritual as voluntary envenomation and outlining its bioactive peptides.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the description of burning and application and the traditionally stated purposes; no claim of benefit follows.
- Supports sections
- Practice Description, Claimed Uses
A single-patient report of seizure and severe hyponatremia after a ritual with high water intake.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports a single Slovenian case; no frequency can be inferred.
- Supports sections
- Terminology, Safety and Suitability
A single-patient report of seizures, severe hyponatremia and rhabdomyolysis after a healing ritual.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports one Chilean case including prior ayahuasca use; no frequency can be inferred.
- Supports sections
- Safety and Suitability
A single-patient report of cerebral edema and brain death after severe hyponatremia following a ritual.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports one case and the authors proposed mechanism; the mechanism is suspected, not established, and no frequency follows.
- Supports sections
- Safety and Suitability
A single-patient report of liver injury probably associated with the ritual.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports one case of probable association; causation is described as probable and no frequency can be inferred.
- Supports sections
- Safety and Suitability
A single-patient report of esophageal rupture following kambô use in Australia.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports a single case of Boerhaave syndrome in an otherwise healthy man and alternative frog names; no frequency can be inferred.
- Supports sections
- Terminology, Safety and Suitability
A single-patient report of acute demyelinating polyneuropathy beginning days after self-applied kambô.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports one case reported as the first electrodiagnostically confirmed; the association is reported by the authors and no frequency follows.
- Supports sections
- Safety and Suitability
A forensic report of a death in a long-term user in which deltorphin A was found in blood.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports one autopsy case in which a link is proposed but not established; no frequency follows.
- Supports sections
- Safety and Suitability
A laboratory paper isolating opioid heptapeptides from Phyllomedusa bicolor skin and testing their binding.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports laboratory receptor-binding findings for isolated peptides only; must not be applied to clinical effects of the secretion.
- Supports sections
- Research and Evidence
Links to Gyfts Kambo page for this practice, for discovery only. The platform's descriptions and claims are not independent claims. Machipedia does not rely on them for evidence.
How this source relates
- Source link
- Exact source page
- Relationship
- Links to Gyfts' page for this practice, for discovery only. The platform's descriptions and claims are not independent evidence, and nothing on this Machipedia page relies on them.
- Supports sections
- Practice Description
Consumer health article on this practice; not evidence and not a Machipedia assessment.
How this source relates
- Source link
- Exact source page
- Relationship
- Links to a Healthline article on this practice, as plain-language consumer context only. It is not independent evidence, and nothing on this Machipedia page relies on it.
- Supports sections
- Practice Description